Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caDC-16-05176/USCOURTS-caDC-16-05176-0/pdf.json

Nature of Suit Code: 410
Nature of Suit: Antitrust
Cause of Action: 

---

United States Court of Appeals

FOR THE DISTRICT OF COLUMBIA CIRCUIT

____________

No. 16-5176 September Term, 2016

1:16-cv-00590-JEB

Filed On: October 19, 2016

Steve Shelden,

Appellant

Alzcog Therapeutics, LLC and Innoventureica,

LLC,

Appellees

v.

United States Department of Justice, Office of

Counsel, et al.,

Appellees

ON APPEAL FROM THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLUMBIA

BEFORE: Brown and Griffith, Circuit Judges; Ginsburg, Senior Circuit Judge

J U D G M E N T

This appeal was considered on the record from the United States District Court for

the District of Columbia and on the brief filed by appellant. See Fed. R. App. P. 34(a)(2);

D.C. Cir. Rule 34(j). It is

ORDERED AND ADJUDGED that the district court’s March 31, 2016 order be

affirmed. Appellant’s complaint was properly dismissed because it was “patently

insubstantial, presenting no federal question suitable for decision.” Tooley v. Napolitano,

586 F.3d 1006, 1009 (D.C. Cir. 2009) (internal quotation marks omitted).

Pursuant to D.C. Circuit Rule 36, this disposition will not be published. The Clerk is

directed to withhold issuance of the mandate herein until seven days after resolution of any

timely petition for rehearing or petition for rehearing en banc. See Fed. R. App. P. 41(b);

D.C. Cir. Rule 41.

Per Curiam

FOR THE COURT:

Mark J. Langer, Clerk

BY: /s/

Ken Meadows

Deputy Clerk

USCA Case #16-5176 Document #1641647 Filed: 10/19/2016 Page 1 of 1